- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/38 - One oxygen atom attached in position 2
Patent holdings for IPC class C07D 263/38
Total number of patents in this class: 62
10-year publication summary
|
10
|
5
|
5
|
5
|
7
|
4
|
5
|
5
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 458 |
19 |
| Novartis AG | 10829 |
3 |
| Takeda Pharmaceutical Company Limited | 2696 |
3 |
| Vectus Biosystems Limited | 35 |
3 |
| BASF SE | 20915 |
2 |
| CHDI Foundation, Inc. | 108 |
2 |
| Denali Therapeutics Inc. | 247 |
2 |
| Symrise AG | 1729 |
2 |
| Theravance, Inc. | 66 |
2 |
| The Regents of the University of California | 19943 |
1 |
| Syngenta Participations AG | 1900 |
1 |
| Sabic Innovative Plastics IP B.V. | 681 |
1 |
| AMOREPACIFIC Corporation | 2834 |
1 |
| Auspex Pharmaceuticals, Inc. | 182 |
1 |
| Chicago Discovery Solutions, LLC | 2 |
1 |
| Moehs Iberica, S.L. | 26 |
1 |
| Provincial Health Services Authority | 188 |
1 |
| The Scripps Research Institute | 1350 |
1 |
| Soochow University | 1738 |
1 |
| Takasago International Corporation | 402 |
1 |
| Other owners | 13 |